New Discoveries in Parkinson's Point to Biomarkers, Therapies

Although Parkinson's disease (PD) is estimated to be the second most common neurodegenerative disorder, very little is known about its underlying cause. That could be about to change as scientists continue to drill down into the molecular machinery implicated in the disease. Recent scientific discoveries are beginning to open up the potential for both the development of innovative approaches to early diagnosis and treatment.